56.26
price up icon2.01%   1.11
after-market 시간 외 거래: 56.26
loading

Protagonist Therapeutics Inc 주식(PTGX)의 최신 뉴스

pulisher
Jul 28, 2025

Protagonist therapeutics CEO Patel sells $570k in stock By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

How does Protagonist Therapeutics Inc. generate profit in a changing economyDiscover top stock picks for aggressive growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Protagonist Therapeutics Inc. stockFree Stock Market Return Analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Protagonist Therapeutics Inc. company’s key revenue driversDaily Trading Picks Backed By Experts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Protagonist Therapeutics Inc. stock higher in 2025Capitalize on trading strategies that deliver - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Protagonist Therapeutics Inc. stockUnlock exclusive stock market forecasts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Protagonist Therapeutics Inc. a growth stock or a value stockGame-changing returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Protagonist Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayShort Squeeze Radar - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Does Protagonist Therapeutics Inc. stock pay reliable dividendsFree Consultation - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Johnson & Johnson Submits NDA for Protagonist-Partnered Icotrokinra to FDA for Plaque Psoriasis - MSN

Jul 25, 2025
pulisher
Jul 24, 2025

Protagonist Therapeutics Inc. Stock Analysis and ForecastExponentially increasing returns - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Protagonist Therapeutics Inc. stockHigh-performance investment picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate - Newport Daily News

Jul 24, 2025
pulisher
Jul 23, 2025

CEO’s Major Stock Sale Shakes Up Protagonist Therapeutics! - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Protagonist Therapeutics CEO Patel sells $2.88 million in shares By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Protagonist Therapeutics CEO Patel sells $2.88 million in shares - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Protagonist Therapeutics Inc. stock priceDynamic capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Protagonist Therapeutics Inc. a good long term investmentBreakout stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis - Lubbock Avalanche-Journal

Jul 22, 2025
pulisher
Jul 21, 2025

Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Protagonist Announces Submission of NDA for First Icotrokinra U. - GuruFocus

Jul 21, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):